Solu Therapeutics
About:
Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
Website: https://solutherapeutics.com
Top Investors: Alexandria Venture Investments, Astellas Venture Management, Sante Ventures, Longwood Fund, DCVC Bio
Description:
Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
Total Funding Amount:
$31M
Headquarters Location:
Boston, Massachusetts, United States
Founded Date:
2022-01-01
Contact Email:
careers(AT)solutherapeutics.com
Founders:
Brandon Turunen, David Donabedian, PhD, John Pribis
Number of Employees:
1-10
Last Funding Date:
2023-08-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai